Phase 3 Study of PF-06801591 in Combination with Bacillus Calmette-Guerin (BCG) in Participants withHigh-Risk Non-Muscle Invasive Bladder Cancer

Project: Research project

Project Details

Description

Phase 3 Study of PF-06801591 in Combination with Bacillus Calmette-Guerin (BCG) in Participants with High-Risk Non-Muscle Invasive Bladder Cancer
StatusActive
Effective start/end date6/11/206/30/25

Funding

  • PFIZER, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.